As presbyopia-correcting drops have started to enter the marketplace, many anterior segment surgeons are talking about what our role in prescribing these drops will be.
Some have questioned whether we ought to devote time and energy at all to a nonsurgical solution. Personally, I see only upside in finding ways to successfully offer presbyopia-correcting drops to our patients.
We can learn some important lessons on this front from our colleagues in plastic surgery who were initially wary of Botox (onabotulinumtoxinA, Allergan) injections and dermal fillers, fearing these nonsurgical procedures